|
|
Article: Researchers at Chinese University of Hong Kong, Institute of Chinese Medicine have published new data on pneumonia therapy.
- Article from:
- Biotech Week
- Article date:
- August 6, 2008
CopyrightCOPYRIGHT 2008 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
A new study, 'Immunomodulatory and anti-SARS activities of Houttuynia cordata,' is now available. "Severe acute respiratory syndrome (SARS) is a life-threatening form of pneumonia caused by SARS coronavirus (SARS-CoV). From late 2002 to mid 2003, it infected more than 8000 people worldwide, of which a majority of cases were found in China," investigators in People's Republic of China report (see also Pneumonia Therapy).
"Owing to the absence of definitive therapeutic Western medicines, Houttuynia cordata Thunb. (Saururaceae)(HC) was shortlisted by Chinese scientists to tackle SARS problem as it is conventionally used to treat pneumonia. The present study aimed to ...